MarketPeel
Insider Trading Intelligence
Pricing
…
DA

Dana Aftab

EXEL
CSO/EVP DISC & TRANS RESEARCH · EXELIXIS, INC. · CIK 0001959132
FILING MIX · LIFETIME29%/71%
BUYS
15
SELLS
37
TOTAL VALUE
$31.81M
COMPANIES
1
ACTIVE SINCE
Jan 2023
HOLDINGS NOW
594,741
AVG SELL PX
$34.50
TRADE KIND
SHOWING 52 / 52
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 14 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Dana Aftab, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+66.67%-1.04%+0.96%-2.00%-2.23%—
14d12+58.33%+0.76%+0.82%-0.06%-0.54%—
30d12+58.33%+1.75%+0.54%+1.22%+0.99%—
60d12+50.00%+1.26%+3.21%-1.95%-1.31%—
90d12+25.00%+9.18%+6.12%+2.89%+3.62%—
180d12(2 pending)+10.00%+15.76%+10.00%+5.76%+9.46%—
1y12(3 pending)+0.00%+24.48%+23.34%+1.14%-1.42%—
2y12(9 pending)+0.00%+100.61%+50.64%+49.97%+61.37%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EXEL · 594,741 shares · as of May 26, 2026
0190,089380,178570,267760,356202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 37 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EXEL
EXELIXIS, INC.
SALE
EVP, Research and Development
43,451$50.35$2.19M594,741May 26, 2026May 28, 2026 ↗View →
EXEL
EXELIXIS, INC.
SALE
EVP, Research and Development
30,578$51.10$1.56M638,192May 15, 2026May 19, 2026 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
52,018——668,124Feb 26, 2026Mar 2, 2026 ↗View →
EXEL
EXELIXIS, INC.
SALE
EVP, Research and Development
47,918$44.50$2.13M616,106Feb 24, 2026Feb 26, 2026 ↗View →
EXEL
EXELIXIS, INC.
SALE
EVP, Research and Development
29,873$44.35$1.32M664,024Feb 19, 2026Feb 23, 2026 ↗View →
EXEL
EXELIXIS, INC.
SALE
EVP, Research and Development
26,485$43.92$1.16M706,617Feb 15, 2026Feb 18, 2026 ↗View →
EXEL
EXELIXIS, INC.
SALE
EVP, Research and Development
12,720$43.92$558.7K693,897Feb 15, 2026Feb 18, 2026 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
119,578——760,356Jan 15, 2026Jan 16, 2026 ↗View →
EXEL
EXELIXIS, INC.
SALE
EVP, Research and Development
27,254$45.23$1.23M733,102Jan 15, 2026Jan 16, 2026 ↗View →
EXEL
EXELIXIS, INC.
SALEGRANT
Gift
24,000——640,778Nov 21, 2025Nov 24, 2025 ↗View →
EXEL
EXELIXIS, INC.
SALE
EVP, Research and Development
48,383$42.50$2.06M664,778Nov 11, 2025Nov 13, 2025 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
50,673——713,161Oct 8, 2025Oct 10, 2025 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
30,693$44.65$1.37M662,488May 15, 2025May 16, 2025 ↗View →
EXEL
EXELIXIS, INC.
SALE10b5-1
10b5-1 plan
1,508$39.00$58.8K693,181May 1, 2025May 5, 2025 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
132,819——693,936Mar 31, 2025Mar 31, 2025 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
49,209——561,117Feb 26, 2025Feb 28, 2025 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
26,987$36.75$991.8K511,908Feb 24, 2025Feb 26, 2025 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
12,695$35.00$444.3K538,895Feb 15, 2025Feb 19, 2025 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
16,053$35.00$561.9K551,590Feb 15, 2025Feb 19, 2025 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
22,570$37.27$841.2K567,643Jan 16, 2025Jan 17, 2025 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
104,106——590,213Jan 16, 2025Jan 17, 2025 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
12,838$35.05$450.0K486,107Nov 15, 2024Nov 19, 2024 ↗View →
EXEL
EXELIXIS, INC.
PURCHASE
CSO/EVP Disc & Trans Research
96,986$18.80$1.82M595,931Nov 5, 2024Nov 7, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
96,986——0Nov 5, 2024Nov 7, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE10b5-1
10b5-1 plan
96,986$35.00$3.39M498,945Nov 5, 2024Nov 7, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE10b5-1
10b5-1 plan
1,162$31.40$36.5K498,945Oct 30, 2024Nov 1, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
20,883$27.06$565.1K500,107Aug 12, 2024Aug 14, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE10b5-1
10b5-1 plan
95,000$25.00$2.38M520,990Aug 7, 2024Aug 9, 2024 ↗View →
EXEL
EXELIXIS, INC.
PURCHASE
CSO/EVP Disc & Trans Research
95,000$24.41$2.32M615,990Aug 7, 2024Aug 9, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
95,000——0Aug 7, 2024Aug 9, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
8,658$20.99$181.7K520,990May 15, 2024May 17, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
6,409$20.99$134.5K537,186May 15, 2024May 17, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
7,538$20.99$158.2K529,648May 15, 2024May 17, 2024 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
63,350——542,381Feb 23, 2024Feb 27, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
10,630$20.39$216.7K479,031Feb 15, 2024Feb 16, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
11,606$22.86$265.3K489,661Jan 11, 2024Jan 16, 2024 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
63,224——501,267Jan 11, 2024Jan 16, 2024 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
12,560$22.27$279.7K438,043Sep 6, 2023Sep 8, 2023 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
50,660——450,603Sep 6, 2023Sep 8, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE10b5-1
10b5-1 plan
4,600$22.47$103.4K399,943Aug 30, 2023Sep 1, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
6,280$21.51$135.1K404,543Aug 15, 2023Aug 17, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
6,115$19.18$117.3K410,823May 15, 2023May 17, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
4,373$19.18$83.9K416,938May 15, 2023May 17, 2023 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
68,331——419,803Apr 3, 2023Apr 5, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
82,490$17.50$1.44M351,472Feb 28, 2023Mar 1, 2023 ↗View →
EXEL
EXELIXIS, INC.
PURCHASE
CSO/EVP Disc & Trans Research
82,490$14.74$1.22M433,962Feb 28, 2023Mar 1, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
82,490——0Feb 28, 2023Mar 1, 2023 ↗View →
EXEL
EXELIXIS, INC.
PURCHASE
CSO/EVP Disc & Trans Research
10$14.74$147351,482Feb 27, 2023Mar 1, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
10$17.50$175351,472Feb 27, 2023Mar 1, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
10——82,490Feb 27, 2023Mar 1, 2023 ↗View →
EXEL
EXELIXIS, INC.
SALE
CSO/EVP Disc & Trans Research
1,529$18.08$27.6K351,472Feb 15, 2023Feb 17, 2023 ↗View →
EXEL
EXELIXIS, INC.
PURCHASEGRANT
Stock grant
100,000——353,001Jan 5, 2023Jan 9, 2023 ↗View →
Other insiders · EXEL
Loading peer insiders…
About this filer
CIK 0001959132
ROLE
CSO/EVP Disc & Trans Research
PRIMARY
EXEL
COMPANIES
1
ACTIVE SINCE
Jan 2023
MARKETPEEL · /INSIDER/0001959132DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback